Boston boosts share in brain monitoring company:
This article was originally published in Clinica
Executive Summary
Boston Scientific has spent $8.1m on acquiring a further 500,000 shares of common stock in Aspect Medical Systems. The two companies had formed a strategic alliance in August 2002 to introduce New York-based Aspect's sedation management technology to new markets. Under this agreement, Boston bought 1.43 million shares of Aspect's stock and provided the New York-based developer of brain monitoring systems with a $5m revolving line of credit. The contract stipulated that Boston could acquire up to 25% of Aspect's outstanding common stock in the market. This recent purchase pushes the Natick, Massachusetts-based company's share of Aspect to 22.5%.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.